The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Salvatore Brugaletta
Showing 1-20 of 47 articles
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Alfonso F,
Cequier A,
Romaní S,
Bordes P,
Serra A,
Iñiguez A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Cuesta J,
Gómez-Hospital JA,
Sabaté M
February 28, 2022 | 10.4244/EIJ-D-21-00651
EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology.
Van Belle E,
Teles R,
Pyxaras S,
Kalpak O,
Johnson T,
Barbash I,
De Luca G,
Kostov J,
Parma R,
Vincent F,
Brugaletta S,
Debry N,
Toth G,
Ghazzal Z,
Deharo P,
Milasinovic D,
Kaspar K,
Saia F,
Mauri Ferre J,
Kammler J,
Muir D,
O'Connor S,
Mehilli J,
Thiele H,
Weilenmann D,
Witt N,
Joshi F,
Kharbanda R,
Piroth Z,
Wojakowski W,
Geppert A,
Di Gioia G,
Pires-Morais G,
Petronio A,
Estévez-Loureiro R,
Ruzsa Z,
Kefer J,
Kunadian V,
Van Mieghem N,
Windecker S,
Baumbach A,
Haude M,
Dudek D
May 16, 2021 | 10.4244/EIJ-D-18-00448
Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion
Freixa X,
Cepas-Guillen P,
Flores-Umanzor E,
Regueiro A,
Sanchís L,
Fernandez-Valledor A,
Brugaletta S,
Carretero M,
Vidal B,
Masotti M,
Martin-Yuste V,
Roqué M,
Sitges M,
Sabaté M
February 5, 2021 | 10.4244/EIJ-D-20-00886
Target lesion revascularisation of bioresorbable metal scaffolds: a case series study and literature review
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Sanchis J,
Fernández-Díaz J,
Artaiz-Urdaci M,
Alfonso F,
Garcia-Garcia H,
Sabaté M
January 20, 2021 | 10.4244/EIJ-D-19-00421
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J,
Ortega-Paz L,
Brugaletta S,
Cuesta J,
Romaní S,
Serra A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Antuña P,
Romaguera R,
Regueiro A,
Rivero F,
Cequier A,
Alfonso F,
Gómez-Hospital JA,
Sabaté M
December 4, 2020 | 10.4244/EIJ-D-20-00198
PCR e-Course: reshaping education in exceptional circumstances
Brugaletta S,
Capodanno D,
Fajadet J,
Wijns W
June 25, 2020 | 10.4244/EIJV16I3A30
Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial
Gomez-Lara J,
Salvatella N,
Romaguera R,
Brugaletta S,
Nato M,
Roura G,
Ferreiro J,
Teruel L,
Gracida M,
Sabaté M,
Vaquerizo B,
Cequier A,
Gomez-Hospital J
June 12, 2020 | 10.4244/EIJ-D-18-01203
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
Brugaletta S,
Gori T,
Tousek P,
Gomez-Lara J,
Pinar E,
Ortega-Paz L,
Schulz E,
Kocka V,
Münzel T,
Cequier A,
Buono A,
Serruys P,
Sabaté M
March 20, 2020 | 10.4244/EIJ-D-19-00773
Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data
Cassese S,
Katagiri Y,
Byrne R,
Brugaletta S,
Alfonso F,
Räber L,
Maeng M,
Iñiguez A,
Kretov E,
Onuma Y,
Joner M,
Sabaté M,
Laugwitz K,
Windecker S,
Kastrati A,
Serruys P
March 20, 2020 | 10.4244/EIJ-D-18-01080
Coronary artery lesion phenotype in frail older patients with non-ST-elevation acute coronary syndrome undergoing invasive care
Gu S,
Mintz G,
Calvert P,
Ford G,
Neely D,
Brugaletta S,
Veerasamy M,
Sinclair H,
Batty J,
Qiu W,
Kunadian V
June 12, 2019 | 10.4244/EIJ-D-18-00848
Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial
Gargiulo G,
Pasquetto G,
Brugaletta S,
Ferrari F,
Casu G,
Guiducci V,
Dellavalle A,
Liistro F,
Mauro C,
van't Hof A,
Omerovic E,
Curello S,
de la Torre Hernandez J,
De Servi S,
Belloni F,
Windecker S,
Penzo C,
Colombo A,
da Costa B,
Frigoli E,
Palmieri C,
Nazzaro M,
Falcone C,
Liso A,
Vigna C,
Abate F,
Comeglio M,
Diletti R,
Gabrielli G,
Di Lorenzo E,
Mazzarotto P,
Zimarino M,
Moretti C,
Valgimigli M
June 12, 2019 | 10.4244/EIJ-D-18-00247
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study
Hioki H,
Brugaletta S,
Ishida K,
Campo G,
Biscaglia S,
Ortega-Paz L,
Cortese B,
Varricchio A,
Latib A,
Sabaté M,
Tespili M,
Ielasi A
May 20, 2019 | 10.4244/EIJ-D-18-00504
Device specificity of vascular healing following implantation of bioresorbable vascular scaffolds and bioabsorbable polymer metallic drug-eluting stents in human coronary arteries: the ESTROFA OCT BVS vs. BP-DES study
de la Torre Hernandez J,
Gonzalo N,
Otaegui I,
Rumoroso J-R,
Gutierrez H,
Alfonso F,
Martí G,
Frutos AS,
Brugaletta S,
Menchero A,
Garcia Camarero T,
Biagioni C,
Escaned J
December 20, 2018 | 10.4244/EIJ-D-17-00952
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen LO,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Serruys P,
Räber L,
Sabaté M,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y,
Onuma Y,
Liu S,
Asano T,
Eggermont J,
Katagiri Y,
Cavalcante R,
de Winter R,
Wykrzykowska J,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Dijkstra J,
Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T,
Katagiri Y,
Collet C,
Tenekecioglu E,
Miyazaki Y,
Sotomi Y,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska J,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Reiber J,
von Birgelen C,
Sabaté M,
Onuma Y,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up
Paoletti G,
Gomez-Lara J,
Brugaletta S,
Nato M,
Romaguera R,
Roura G,
Ferreiro JL,
Teruel L,
Gracida M,
Ortega-Paz L,
Gomez-Hospital J,
Sabaté M,
Cequier A
June 20, 2018 | 10.4244/EIJ-D-17-00255
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial
von Birgelen C,
Asano T,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska J,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Onuma Y,
Serruys P,
Sabaté M
April 20, 2018 | 10.4244/EIJ-D-17-00462
First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold
Kochman J,
Kołtowski Ł,
Tomaniak M,
Jąkała J,
Proniewska K,
Legutko J,
Roleder T,
Pietrasik A,
Rdzanek A,
Kochman W,
Brugaletta S,
Opolski G,
Regar E
April 6, 2018 | 10.4244/EIJ-D-17-00311
Moving fast towards the future: the role of #SoMe in learning cardiology
Brugaletta S
March 20, 2018 | 10.4244/EIJV13I16A305
1
2
3
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke